期刊
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
卷 54, 期 11, 页码 702-707出版社
WILEY-BLACKWELL
DOI: 10.1002/jlcr.1911
关键词
[C-11]RO5013853; carbon-11; PET; GlyT1; glycine; transporter; radiolabeling
The glycine transporter type 1 (GlyT1) has emerged as a key novel target for the treatment of schizophrenia. We have recently discovered and developed [C-11]RO5013853 as a novel positron emission tomography tracer for GlyT1 for which a reliable five-step synthetic route was established. The incorporation of the radioisotope was achieved in the final step through methylation of a sodium sulfinate precursor, itself easily accessible upon reduction of the corresponding sulfonyl-chloride analog. [C-11]RO5013853 was prepared with high specific activity (>49GBq/mu mol) and high radiochemical purity (100%). A validation study of [C-11]RO5013853 in animal imaging studies is in progress.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据